Journal Watch · Briefings in Bioinformatics · 2026

MELGene: knowledge-enhanced multimodel ensemble learning for disease-gene association prediction.

MELGene offers a flexible framework for DGP through knowledge enhancement and adaptive ensemble learning, with broad potential for decoding disease mechanisms.

Tian H, Yang K, Liu Z et al.Briefings in Bioinformatics3 min readPharma relevance 40/100

DOI: 10.1093/bib/bbag172PMID: 41985062Study type: research study

TL;DR

MELGene offers a flexible framework for DGP through knowledge enhancement and adaptive ensemble learning, with broad potential for decoding disease mechanisms.

Key findings

  • The framework incorporates Model-aware Importance Learning, which dynamically adjusts the contributions of individual models, and introduces a dynamic ensemble mechanism to obtain robust consensus predictions.
  • Finally, we conducted comprehensive experiments, including performance comparisons, which demonstrated the excellent performance of MELGene.
  • Ablation experiments highlighted the positive impact of each module, while case studies showcased the reliability of the biological relevance of gastric, lung, and liver cancers, as supported by the analysis of network medicine, functional enrichment, and literature mining.
  • MELGene offers a flexible framework for DGP through knowledge enhancement and adaptive ensemble learning, with broad potential for decoding disease mechanisms.

What they did

These intricate interactions are essential for learning robust representations of phenotypes and genotypes, which are critical for accurate DGP. In this study, we introduce MELGene, a knowledge-enhanced multimodel ensemble learning framework for DGP. MELGene leverages an adaptive integration of multiple pretrained knowledge inference models based on knowledge graph, effectively integrating the collective intelligence of diverse models to achieve more accurate gene predictions.

Full abstract (original)

Background: Disease-gene prediction (DGP) plays a pivotal role in understanding the genetic underpinnings of various diseases, offering insights for disease diagnosis, treatment, and prevention. Accurate identification of disease-related genes can enhance personalized medicine and the development of targeted therapies. While numerous methods for DGP have been proposed in the field, a significant challenge remains in effectively capturing and modeling the complex relationships among biological entities, such as diseases, symptoms, genes, and pathways.

What they did: These intricate interactions are essential for learning robust representations of phenotypes and genotypes, which are critical for accurate DGP. In this study, we introduce MELGene, a knowledge-enhanced multimodel ensemble learning framework for DGP. MELGene leverages an adaptive integration of multiple pretrained knowledge inference models based on knowledge graph, effectively integrating the collective intelligence of diverse models to achieve more accurate gene predictions.

Results & conclusions: The framework incorporates Model-aware Importance Learning, which dynamically adjusts the contributions of individual models, and introduces a dynamic ensemble mechanism to obtain robust consensus predictions. Finally, we conducted comprehensive experiments, including performance comparisons, which demonstrated the excellent performance of MELGene. Ablation experiments highlighted the positive impact of each module, while case studies showcased the reliability of the biological relevance of gastric, lung, and liver cancers, as supported by the analysis of network medicine, functional enrichment, and literature mining. MELGene offers a flexible framework for DGP through knowledge enhancement and adaptive ensemble learning, with broad potential for decoding disease mechanisms.

Abstract © the authors / Briefings in Bioinformatics (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1093/bib/bbag172 · PubMed 41985062.

Why it matters for pharma & biotech

  • Relevant to Biotechnology & Methods teams tracking Briefings in Bioinformatics for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Briefings in Bioinformatics study find?

MELGene offers a flexible framework for DGP through knowledge enhancement and adaptive ensemble learning, with broad potential for decoding disease mechanisms.

What type of study is this?

It is a research study, published in Briefings in Bioinformatics in 2026. These intricate interactions are essential for learning robust representations of phenotypes and genotypes, which are critical for accurate DGP.

Where can I read the original paper?

The original is at the publisher via DOI 10.1093/bib/bbag172. PubMed ID: 41985062. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Tian H, Yang K, Liu Z et al.. MELGene: knowledge-enhanced multimodel ensemble learning for disease-gene association prediction.. Briefings in Bioinformatics (2026). DOI: 10.1093/bib/bbag172.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/melgene-knowledge-enhanced-multimodel-ensemble-learning-for-disease-gene-bag172/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides